Kiniksa Pharmaceuticals 주식 가격. KNSA - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

20.38

매수가

20.36

매도가

20.40

거래량

302,272

19.60 일간 변동폭 20.73

16.56 52주 범위 28.15

market_cap

1.471B

전일 종가

19.63

개장가

19.75

최근 거래 시간

20.3727

마지막 거래 시간

05:30:48

재정 규모

US$ 6,080,958

VWAP

20.1175

평균 볼륨(3m)

424,219

발행 주식

72,201,565

배당수익률

주가수익률

104.92

주당순이익(EPS)

0.2

매출

270.26M

순이익

14.08M

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. 더 보기

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.kiniksa.com

본부

London, Gbr

설립됨

Kiniksa Pharmaceuticals International PLC is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker KNSA. The last closing price for Kiniksa Pharmaceuticals was US$19.63. Over the last year, Kiniksa Pharmaceuticals shares have traded in a share price range of US$ 16.56 to US$ 28.15.

Kiniksa Pharmaceuticals currently has 72,201,565 shares in issue. The market capitalisation of Kiniksa Pharmaceuticals is US$1.42 billion. Kiniksa Pharmaceuticals has a price to earnings ratio (PE ratio) of 104.92.

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.45	-2.1603456553	20.83	20.83	18.52	610593	19.27132411	CS
4	0.27	1.34261561412	20.11	20.9	17.82	634618	19.37465727	CS
12	-2.08	-9.26090828139	22.46	22.57	17.82	424219	20.05966745	CS
26	-3.89	-16.0280181294	24.27	28.15	17.82	387874	22.6430615	CS
52	1.99	10.8210984231	18.39	28.15	16.56	403826	21.62306454	CS
156	10.08	97.8640776699	10.3	28.15	7.36	391163	16.69741962	CS
260	4.13	25.4153846154	16.25	33	7.36	393359	16.67795102	CS

KNSA - Frequently Asked Questions (FAQ)

What is the current Kiniksa Pharmaceuticals share price?

The current share price of Kiniksa Pharmaceuticals is US$ 20.38

How many Kiniksa Pharmaceuticals shares are in issue?

Kiniksa Pharmaceuticals has 72,201,565 shares in issue

What is the market cap of Kiniksa Pharmaceuticals?

The market capitalisation of Kiniksa Pharmaceuticals is USD 1.42B

What is the 1 year trading range for Kiniksa Pharmaceuticals share price?

Kiniksa Pharmaceuticals has traded in the range of US$ 16.56 to US$ 28.15 during the past year

What is the PE ratio of Kiniksa Pharmaceuticals?

The price to earnings ratio of Kiniksa Pharmaceuticals is 104.92

What is the cash to sales ratio of Kiniksa Pharmaceuticals?

The cash to sales ratio of Kiniksa Pharmaceuticals is 5.47

What is the reporting currency for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Kiniksa Pharmaceuticals?

The latest annual turnover of Kiniksa Pharmaceuticals is USD 270.26M

What is the latest annual profit for Kiniksa Pharmaceuticals?

The latest annual profit of Kiniksa Pharmaceuticals is USD 14.08M

What is the registered address of Kiniksa Pharmaceuticals?

The registered address for Kiniksa Pharmaceuticals is THIRD FLOOR, 23 OLD BOND STREET, LONDON, W1S 4PZ

What is the Kiniksa Pharmaceuticals website address?

The website address for Kiniksa Pharmaceuticals is www.kiniksa.com

Which industry sector does Kiniksa Pharmaceuticals operate in?

Kiniksa Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
LTRYLottery com Inc	US$ 1.355 (176.59%)	241.49M
APPSDigital Turbine Inc	US$ 4.6912 (84.69%)	108.69M
QNTMQuantum Biopharma Ltd	US$ 15.75 (83.57%)	34.29M
LIPOLipella Pharmaceuticals Inc	US$ 4.58 (77.52%)	84.89M
MSPRMSP Recovery Inc	US$ 2.6884 (51.89%)	11.3M
SDASunCar Technology Group Inc	US$ 5.385 (-36.20%)	4.45M
BTAIBioXcel Therapeutics Inc	US$ 0.1909 (-36.13%)	8.51M
SRTSSensus Healthcare Inc	US$ 5.95 (-33.82%)	2.64M
CRMLCritical Metals Corporation	US$ 5.885 (-32.51%)	863.58k
RETOReTo Eco Solutions Inc	US$ 0.5536 (-30.80%)	699.77k
MGOLMGO Global Inc	US$ 0.181 (30.22%)	323.57M
LTRYLottery com Inc	US$ 1.36 (177.61%)	241.5M
NVDANVIDIA Corporation	US$ 128.03 (2.56%)	201.52M
CYNCYNGN Inc	US$ 0.0814 (-0.73%)	128.03M
RIMEAlgorhythm Holdings Inc	US$ 0.0216 (3.35%)	114.26M